Tandem Labs serves the pharmaceutical, biopharmaceutical, and biotechnical industry by combining advanced analytical instrumentation with superior technical expertise. We develop, validate, and perform mass spectrometry-based methods in support of clinical, pre-clinical, and discovery studies in a stringent GLP environment.
A summary of our services is as follows:
GLP Bioanalytical Services:
- Method development
- Method validation
- Dose formulation analysis
- Pre-clinical and clinical sample analysis
- TK/PK analysis and reporting
- Protein-binding studies.
GLP Immunoanalytical Services:
- Biomarker assay development, validation, and sample analysis
- Ligand-binding assays
- Biotherapeutic macromolecule PK
- Immunogenicity assays
- Cell-based assays (bioassays)
- Quantitative immunoassays: EIA, CIA, FIA, IRMA, SPA
- Electrochemiluminescence using MSD & BioVeris™
- Multiplexed assays.
Rapid Turnaround Non-GLP Discovery Services:
- Protein-binding assays
- Discovery bioanalysis (non-GLP, PK screening through candidate selection, and optimization)
Biotransformation and Pharmacodynamics (PK/PD) Services:
- DMDiscoverySM for drug metabolite profiling, identification, and quantification
- MarkerScanSM for biomarker discovery and screening.
At Tandem we are dedicated to meeting the highest standards of personal service, integrity of data, and timeliness for every client.
Search